Skip navigation
Vienna Business Agency
  • Login
  • Deutsch
Vienna Business Agency
  • About us
    • The company
      • Organisation
        • Gender and Diversity
        • Compliance
        • Images
      • Team
  • Funding
    • Programs
    • Online funding application
    • Information
      • Let's talk funding.
  • Consulting
    • Let's talk business.
  • Property
    • Property
    • Technology Centre Seestadt
    • Gewerbehof Seestadt
    • Working space
      • Office space for rent
        • ENERGYbase
        • Mariahilfer Straße
        • Stutterheimstraße
        • Technology Centre Seestadt
      • Labs for rent
      • Office-Services
    • Location development
      • Grätzelinitiative
      • Media Quarter Marx
      • Vienna Biocenter
      • Vienna Business Districts
      • Vienna Innovation Area
  • International Business
    • International Business
    • Business settlement in Vienna
    • Expat in Vienna
  • Startup City Vienna
    • Startup in Vienna
    • Current Calls & Competitions
    • Startup ecosystem
    • FAQs
  • Startup and grow
    • Let's talk founding.
      • Consulting & orientation
      • Coaching
      • Academy workshops
      • Founders Lab
  • Technology
    • Let's talk innovation.
    • Discover technology
      • Workshops for schoolgroups
      • Science Festival 2022
    • Co-Creation Lab Vienna
      • Co-creation lab
  • Creative Industries
    • Developing Vienna's creative industries
    • Mission: creative industries
    • Make things happen
      • Creative Days Vienna
      • Challenges
      • Added value cooperation
    • Competitions
      • Creatives for Vienna
      • Content Vienna
  • News, Workshops and Events
    • News
    • Events
    • Academy-Workshops
  • Viennese stories
    • Overview
    • #viennagoeson
      • Goldsmith Avalone
      • Compact Electric
      • FATEEVA
      • Ferrari Zöchling
      • House of SUPERSENSE
      • Innenhofstudios
      • Media Apparat
      • Silvia Müller
      • Vanillas
      • feinedinge*
      • Glein
    • Urban Food
      • blün
      • Fleischerei Klaghofer
      • iss mich!
      • Kasnudl
      • markta and unverschwendet
      • Viennese Obstraupe
      • Revo Foods
      • Vollpension
      • Wiegert
    • Life Sciences
      • Apeiron
      • G.ST Antivirals
      • One of the largest axolotl colonies in the world lives at the Vienna BioCenter
      • Marinomed
      • mySugr
      • PreGenerate
    • Attraktion!
    • Mate Matcher
    • Pocket Cocktails
    • Bookshop Seeseiten
    • Scissor, stone, paper from vienna

Marinomed

@Jansenberger Fotografie/Marinomed

Red algae eredicates the common cold virus

Viennese life sciences company Marinomed successfully sells products in 35 countries for the treatment of the common cold.

The roughly 200 different cold virus strains lurking in the air are as ubiquitous as the topic of the common cold itself. Once they have established themselves in the nasal mucous membrane, the body tries to get rid of the pathogens by increasing mucus production. On average, adults come down with a cold at least twice a year.

The work of the Viennese company Marinomed Biotechnologie focuses on this topic, and produces innovative nasal and throat sprays that stop the spread of viruses in the body. In contrast to other preparations, Marinomed products not only combat the symptoms of the cold, but also have a clinically proven effect against the cause. Colds and flu-like infections are of shorter duration or don’t occur at all.

From Vienna to the world

The patented active substance is called Carragelose. It is a polymer (a chemical compound of chain or branched molecules) that is obtained from red algae. The polymer envelops the cold viruses and prevents them from attaching to and penetrating the cells of the nasal mucous membrane. As a result, viruses that have already entered cannot multiply. At the same time, the active ingredient forms a shield of moisture in the nose that prevents the mucous membrane from drying out.

Marinomed’s management team is predominantly female. Eva Prieschl-Grassauer is CSO and co-founder of the company. Together with Angelika Bodenteich, she controls Marinomed’s entire product development. The two researchers possess many years of experience in the field of life sciences, where they have specialised in immunology, virology, and product development. Shortly after the foundation of the company in 2006, its first product – Coldamaris – was available on the domestic market.

In 2008, the innovative active substance was first approved for the international market. Today, Marinomed successfully sells its products to treat colds and influenza infections in 35 countries, and currently employs 25 people. Last year, Marinomed was awarded first place in the prestigious Houska Award of the B&C Private Foundation. The Houska Award is the largest private research award in Austria and is endowed with EUR 400,000.

New: relief for allergy sufferers

Currently, product development is focusing on two main areas: In addition to further expanding the existing product line, a combination product tailored to the needs of allergy sufferers is being developed. For people suffering from allergies, viral infections of the respiratory tract often cause the allergy to worsen, and can even contribute to the development of asthma. The forthcoming combination product aims to put a stop to this by offering effective protection against viral infection.

Over the past few years, Marinomed was able to bring several investors on board. Recently, aws Mittelstandsfonds and Invest Unternehmenbeteiligungs AG invested in the successful expansion of the company. Marinomed was also funded by the Vienna Business Agency. Investments will continue to push research forward, and the marketing for existing products will have an increasingly international focus. Since July 2017, Marinomed has been preparing for its initial public offering. They have been able to issue convertible bonds worth over seven million euros on Vienna’s capital market. The investment is now paying off for those that invested in the bonds. Marinomed was listed on the Vienna Stock Exchange in February 2019.

Marinomed can also be found on the Vienna Business Agency's database (in german).

Services of the Vienna Business Agency

  • Funded through the programme Technology Awareness 2014
  • Funded through the Programme Life Sciences 2014
  • Funded through the programme Before FemPower 2007
  • Funded through the programme Startup 2002 und 2005

Company contact:

Marinomed Biotechnologie GmbH
Veterinärplatz 1
1210 Vienna, Austria
www.marinomed.at
 

  • Contact
  • Newsletter
  • Jobs
  • Press
  • Imprint
  • Data protection

Vienna Business Agency.
A service offered by the
City of Vienna.

Mariahilfer Straße 20 1070 Vienna Austria

+43 1 25200

  • Facebook
  • LinkedIn

Cookies

We are constantly working to improve our services. We use cookies to tailor our content to your needs as best as possible.

Data protection

Analysis

no
yes
Google Analytics
no
yes
Google Ireland Limited Show details Hide details

Purpose: technical enablement for the use of analysis tools
Processing operations: no collection of personal data
Storage duration: -
Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Legal basis for data processing: voluntary, revocable consent at any time
Consequences of non-consent: No direct effect on the function of the website; However, limited possibilities for further development and error analysis

Marketing

no
yes
Facebook Pixel
no
yes
Facebook Ireland Ltd. Show details Hide details

Purpose: error analysis, statistical evaluation of our website access, campaign analysis, conversion tracking, retargeting
Processing operations:
Http headers – contain IP addresses, web browser information, page location, document, referrer and website visitor.
Pixel-specific data - e.g. the pixel ID and the Facebook cookie.
Button Click Data - Labels and any pages viewed as a result of clicking the button.
Optional Values ​​– Developers and marketers can optionally send additional visit information via personalized data events. Examples of personalized data events include conversion value, page type, and more.
Form Field Names - This includes the names of website fields such as email, address, and quantity.
Storage period: Facebook stores data until it is no longer needed or until your Facebook account is deleted, whichever comes first.
Joint controller: Facebook Ireland Ltd., 4 Grand Canal Square, Grand Canal Harbour, Dublin 2 Ireland
Legal basis for data processing: voluntary, revocable consent at any time
Consequences of non-consent: No direct effect on the function of the website; However, limited possibilities for further development and error analysis
Data transmission to the USA: Your data will be processed by the provider Facebook in the USA, which involves corresponding risks, e.g. B. secret data access by US authorities. With your consent, you also agree to the processing of your data in the USA.